AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ardanuy, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ardanuy, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2006, p. 3162-3165, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00269-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Increase of the M Phenotype among Erythromycin-Resistant Streptococcus pneumoniae Isolates from Spain Related to the Serotype 14 Variant of the Spain9V-3 Clone

C. Ardanuy,1* A. Fenoll,2 S. Berrón,2 L. Calatayud,1 J. Liñares,1 and the Spanish Pneumococcal Infection Study Network{dagger}

Servicio de Microbiología, Hospital de Bellvitge, Barcelona, Spain,1 CNM Instituto de Salud Carlos III, Madrid, Spain2

Received 3 March 2006/ Returned for modification 9 April 2006/ Accepted 11 June 2006


   ABSTRACT
Top
 Abstract
Text
 References
 
Between 1998 and 2003 the rate of erythromycin resistance among pneumococci in Spain was 34.4%. Although the MLSB phenotype was prevalent (94.7%), the rate of the M phenotype increased from 3.3% to 8.9% (P < 0.01). Clonal dissemination of mef(E)-carrying strains of serotype 14 variant of the Spain9V-3 clone was the major contributor to this increase.


   TEXT
Top
 Abstract
 Text
References
 
Increased resistance to macrolide in Streptococcus pneumoniae has been described worldwide (8-10, 14-16, 18-21, 23-27). In Europe, Mediterranean countries have the highest rates of erythromycin-resistant pneumococci, whereas northern European countries have the lowest (14-16, 20, 23, 29). In Spain, the rate of erythromycin resistance has increased progressively, from 4.3% in the period from 1979 to 1990 (19) to 22.5% in the period from 1990 to 1996 (14) and 34.5% in 2001 and 2002 (26).

Macrolide resistance in pneumococci is mainly mediated by two mechanisms: enzymatic target site modifications mediated by ErmB methylases that confer the MLSB phenotype and active drug efflux pumps encoded by mef genes that confer the M phenotype. Other less frequent mechanisms have also been described: point mutations in ribosomal proteins L4 and L22 or in 23S rRNA (17, 28). The MLSB phenotype is prevalent in Spain and in most European countries, whereas the M phenotype predominates in North America, England, and Greece (1, 8, 15, 21, 29).

In this paper, macrolide-resistant pneumococci with the M phenotype from Spain were investigated.

Evolution of macrolide resistance in pneumococci. Among 15,084 pneumococci recorded at the Spanish Reference Laboratory (1998 to 2003), 5,194 (34.4%) were erythromycin resistant. By the disk diffusion method (31) 4,917 (94.7%) showed the MLSB phenotype and 277 (5.3%) showed the M phenotype (134 isolates were from blood, 55 were from the lower respiratory tract, 20 were from patients with otitis, 21 were from patients with conjunctivitis, and 47 were from miscellaneous sources). Table 1 shows the evolution of rates of erythromycin resistance and the phenotypes. Although the MLSB phenotype is dominant among erythromycin-resistant pneumococci, our study shows that the proportions of isolates with the M phenotype increased significantly from 3.3% in 1998 to 8.9% in 2003 (P < 0.01) (Table 1). Similar rates of the M phenotype were found among erythromycin-resistant isolates from children (age, <15 years) and adults (4.6% and 5.1%, respectively).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Evolution of resistance, phenotypes, and related serotypes of erythromycin-resistant pneumococci

 
Resistance genes. Classically, two mef genes have been identified in pneumococci, mef(A) and mef(E), and these are carried by different genetic elements (6). The mef(A) gene, which is usually found in serotype 14 strains of the England14-9 clone, is carried by a defective transposon (Tn1207.1), whereas the mef(E) gene, which has been identified in different serotypes and clones, is located in the MEGA element (2, 6-9, 21, 24, 34). Recently, a new mef gene, mef(I), has been described in two serotype 11A strains (sequence type 1774 [ST1774]) (4).

The mef gene was detected by PCR (32) in all 277 M-phenotype pneumococci studied. After digestion with BamHI (24), 242 (87.4%) isolates had the mef(E) gene [this approach could not differentiate between mef(E) and mef(I)] and 35 (12.6%) had the mef(A) gene.

Consistent with the findings of previous studies (1, 17), we found that the erythromycin MICs of mef(A)-carrying pneumococci were higher (range, 8 to 128 µg/ml; geometric mean, 29.0 µg/ml) than those of mef(E)-carrying strains (range, 2 to 128 µg/ml; geometric mean, 12.9 µg/ml). These findings could be due to structural differences in the protein or at the site of codifying genes (1).

Only 30 (12.4%) of 242 mef(E)-carrying isolates were tetracycline resistant [positive for tet(M) and int genes by PCR (1, 7)] and had unrelated pulsed-field gel electrophoresis (PFGE) patterns. The association of the mef(E) and the tet(M) genes was reported previously (1, 25, 30), and the genetic element harboring both genes, Tn2009, was recently described (7).

Serotypes and genotypes related to mef genes. Serotyping and PFGE (SmaI) were performed with all mef-carrying isolates, as described previously (14, 22, 33). Twelve strains with the dominant PFGE patterns were selected for multilocus sequence typing (MLST) (12).

Nineteen different serotypes were found among 242 mef(E)-carrying isolates, with the most frequent being serotype 14 (55.8%), nontypeable (10.3%), and serotype 11A (7.9%). Ninety-two PFGE patterns were observed among the mef(E)-carrying strains, with the Spain9V-3 clone (55.8%) and genotype 11A-ST62 (7.0%) being the major clones found (Table 2). Thirty-one (88.6%) of 35 mef(A)-carrying isolates were serotype 14 and belonged to the England14-9 clone (Tables 2 and 3).


View this table:
[in this window]
[in a new window]
  		TABLE 2. Evolution of pneumococcal genotypes related to the mef(A) or mef(E) gene

 

View this table:
[in this window]
[in a new window]
  		TABLE 3. Characteristics of strains selected for MLST

 
Five of 26 international clones described by the Pneumococcal Molecular Epidemiology Network (22) were resistant to macrolides, with the resistance encoded by mef genes. Two of them, England14-9 and Taiwan19F-14 (13, 21), are the major contributors to the worldwide dissemination of M-phenotype strains (http://www.mlst.net). In contrast, our results show that the majority (48.7%, 135/277) of the M-phenotype pneumococci isolated in Spain belonged to the Spain9V-3 clone and harbored the mef(E) gene, whereas only 11.2% (35/277) of the strains belonged to the England14-9 clone and harbored the mef(A) gene (Table 2). No Taiwan19F-14 clone was observed among the 16 serogroup 19 isolates studied.

The Spain9V-3 clone was first identified in 1987 in Spain and France and is now one of the most important invasive pneumococci worldwide (www.mlst.net) (5). Strains of this clone are usually resistant to penicillin and co-trimoxazole; however, since 1998 some strains of this clone have acquired the mef(E) gene (20). In the United States, only 37 (14.1%) of mef(E)-carrying strains were related to the Spain9V-3 clone (21), and all but one were of serotype 9V. In contrast, we found that 96.3% of the mef(E)-carrying pneumococci of the Spain9V-3 clone were serotype 14, demonstrating a phenomenon of capsular switching between serotypes 9V and 14.

The England14-9 clone harboring mef(A) has been described as predominant among M-phenotype pneumococci isolated in England, Italy, and Greece (1, 6, 15, 24). In our study this clone ranked second. In contrast, the strains of the England14-9 clone described in the United States carried the mef(E) gene (21).

Strains of serotype 11A with ST62 have previously been found in Spain among erythromycin-susceptible pneumococci causing meningitis (11). Our results show that isolates of genotype 11A-ST62, which harbor the mef(E) gene, rank third among the M-phenotype pneumococci isolated in Spain. Strains of serotype 11A harboring the mef(A) gene have been sporadically described in Italy (23), and strains of serotype 11A harboring the mef(E) gene have been described in Hungary (9) and Canada (34).

In common with other findings (34), our results show that a third of the mef(E) isolates had unrelated genotypes, thus suggesting the horizontal spread of this gene. We previously reported a high prevalence of macrolide resistance mediated by the mef(E) gene in viridans group streptococci (2), which may act as a reservoir of the mef(E) gene and contribute to the horizontal transmission of macrolide resistance in pneumococci, as is the case in other resistance genes (3).

In conclusion, although the mef(E) gene may spread horizontally, the clonal dissemination of the serotype 14 variant of the Spain9V-3 clone harboring the mef(E) gene is a major contributor to the emergence of M-phenotype pneumococci in Spain.


   ACKNOWLEDGMENTS
 
This work was supported by the Spanish Pneumococcal Infection Study Network G03/103 (Red Temática de Cooperación del Fondo de Investigaciones Sanitarias de la Seguridad Social). We are grateful for permission to use the pneumococcal MLST database at Imperial College London, funded by the Wellcome Trust.

We thank Elena Pérez for her excellent technical support.

The general coordinator of the Spanish Pneumococcal Infection Study Network (G03/103) is Román Pallarés. The participants and centers include Ernesto García (Centro de Investigaciones Biológicas, Madrid); Julio Casal, Asunción Fenoll, and Adela G. de la Campa (Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid); Emilio Bouza (Hospital Gregorio Marañón, Madrid); Fernando Baquero (Hospital Ramón y Cajal, Madrid); Francisco Soriano and José Prieto (Fundación Jiménez Díaz and Facultad de Medicina de la Universidad Complutense, Madrid); Román Pallarés and Josefina Liñares (Hospital Universitari de Bellvitge, Barcelona); Javier Garau and Javier Martínez Lacasa (Hospital Mutua de Terrassa, Barcelona); Cristina Latorre (Hospital Sant Joan de Déu, Barcelona); Emilio Pérez-Trallero (Hospital Donostia, San Sebastián); Juan García de Lomas (Hospital Clínico, Valencia); and Ana Fleites (Hospital Central de Asturias).


   FOOTNOTES
 
* Corresponding author. Mailing address: Servicio de Microbiología, Hospital de Bellvitge, Feixa Llarga s/n, 08907 l'Hospitalet de Llobregat, Barcelona, Spain. Phone: 34 93 260 79 30. Fax: 34 93 260 75 47. E-mail: c.ardanuy{at}csub.scs.es. Back

{dagger} The members of the Spanish Pneumococcal Infection Study Network are provided in Acknowledgments. Back


   REFERENCES
Top
 Abstract
 Text
 References
 

  1. Amezaga, M. R., P. E. Carter, P. Cash, and H. McKenzie. 2002. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J. Clin. Microbiol. 40:3313-3318.[Abstract/Free Full Text]
  2. Ardanuy, C., F. Tubau, J. Liñares, M. A. Domínguez, R. Pallarés, R. Martín, and The Spanish Pneumococcal Infection Study Network (G03/103). 2005. Distribution of subclasses mef(A) and mef(E) of the mef(A) gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes. Antimicrob. Agents Chemother. 49:827-829.[Abstract/Free Full Text]
  3. Bryskier, A. 2002. Viridans group streptococci: a reservoir of resistant bacteria in oral cavities. Clin. Microbiol. Infect. 8:65-69.[CrossRef][Medline]
  4. Cochetti, I., M. Vecchi, M. Mingoia, E. Tili, M. R. Catania, A. Manzin, P. E. Valardo, and M. P. Montanari. 2005. Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I). Antimicrob. Agents Chemother. 49:4999-5006.[Abstract/Free Full Text]
  5. Coffey, T. J., M. Daniels, M. C. Enright, and B. G. Spratt. 1999. Serotype 14 variants of the Spanish penicillin resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a region. Microbiology 145:2023-2031.[Abstract]
  6. Del Grosso, M., F. Iannelli, C. Messina, M. Santagati, N. Petrosillo, S. Stefani, G. Pozzi, and A. Pantosi. 2002. Macrolide efflux genes mef(A) and mef(E) are carried by different genetics elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40:774-778.[Abstract/Free Full Text]
  7. Del Grosso, M., A. Scotto d'Abusco, F. Iannelli, G. Pozzi, and A. Pantosi. 2004. Tn2009, a Tn916-like element containing mef(E) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48:2037-2042.[Abstract/Free Full Text]
  8. Dias, R., and M. Canica. 2004. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. J. Antimicrob. Chemother. 54:1035-1039.[Abstract/Free Full Text]
  9. Dobay, O., F. Rozgonyi, and S. G. Amyes. 2005. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene. Int. J. Antimicrob. Agents 25:488-495.[CrossRef][Medline]
  10. Doern, G. V., K. P. Heilmann, H. K. Huynh, P. R. Rhomberg, S. L. Coffman, and A. B. Brueggemann. 2001. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:1721-1729.[Abstract/Free Full Text]
  11. Enright, M. C., A. Fenoll, D. Griffiths, and B. G. Spratt. 1999. The three major Spanish clones of penicillin-resistant Streptococcus pneumoniae are the most common clones recovered in recent cases of meningitis in Spain. J. Clin. Microbiol. 37:3210-3216.[Abstract/Free Full Text]
  12. Enright, M. C., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.[Abstract]
  13. Farrell, D. J., S. G. Jenkins, S. D. Brown, M. Patel, B. S. Lavin, and K. P. Klugman. 2005. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg. Infect. Dis. 11:851-858.[Medline]
  14. Fenoll, A., I. Jado, D. Vicioso, A. Pérez, and J. Casal. 1998. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J. Clin. Microbiol. 36:3447-3454.[Free Full Text]
  15. Fotopoulou, N., P. T. Tassios, D. V. Beste, S. Ioannidou, A. Efstratiou, E. R. Lawrence, J. Papaparaskevas, R. C. George, and N. J. Legakis. 2003. A common clone of erythromycin-resistant Streptococcus pneumoniae in Greece and the UK. Clin. Microbiol. Infect. 9:924-929.[CrossRef][Medline]
  16. Jacobs, M. R., D. Felmingham, P. C. Appelbaum, R. N. Grüneberg, and the Alexander Project Group. 2003. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J. Antimicrob. Chemother. 52:229-246.[Abstract/Free Full Text]
  17. Klaassen, C. H. W., and J. W. Mouton. 2005. Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E). Antimicrob. Agents Chemother. 49:1271-1278.[Free Full Text]
  18. Klugman, K. P., and J. R. Lonks. 2005. Hidden epidemic of macrolide resistant pneumococci. Emerg. Infect. Dis. 11:802-807.[Medline]
  19. Liñares, J., R. Pallarés, T. Alonso, J. L. Pérez, J. Ayats, F. Gudiol, P. F. Viladrich, and R. Martín. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99-105.[Medline]
  20. Marimon, J. M., L. Iglesias, D. Vicente, and E. Perez-Trallero. 2003. Molecular characterization of erythromycin-resistant clinical isolates of the four major antimicrobial-resistant Spanish clones of Streptococcus pneumoniae (Spain23F-1, Spain6B-2, Spain9V-3, and Spain14-5). Microb. Drug Resist. 9:133-137.[CrossRef][Medline]
  21. McEllistrem, M. C., J. M. Adams, K. Shutt, J. T. Sanza, R. R. Facklam, C. G. Whitey, J. H. Jorgensen, and L. H. Harrison. 2005. Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001. Emerg. Infect. Dis. 11:969-972.[Medline]
  22. McGee, L., L. McDougal, J. Zhou, B. G. Spratt, F. C. Tenover, R. George, R. Hakenbeck, W. Hryniewicz, J. C. Lefevre, A. Tomasz, and K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.[Abstract/Free Full Text]
  23. Monaco, M., R. Camilli, F. D'Ambrosio, M. del Grosso, and A. Pantosi. 2005. Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy. J. Antimicrob. Chemother. 55:256-259.[Abstract/Free Full Text]
  24. Montanari, M. P., M. Mingoia, I. Cochetti, and P. E. Varaldo. 2003. Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy. J. Clin. Microbiol. 41:428-431.[Abstract/Free Full Text]
  25. Montanari, M. P., I. Cochetti, M. Mingoia, and P. E. Varaldo. 2003. Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:2236-2241.[Abstract/Free Full Text]
  26. Pérez-Trallero, E., C. García-de-la-Fuente, C. García-Rey, F. Baquero, L. Aguilar, R. Dal-Ré, J. García-de-Lomas and The Spanish Surveillance Group for Respiratory Pathogens. 2005. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob. Agents Chemother. 49:1965-1972.[Abstract/Free Full Text]
  27. Reinert, R. R., A. Ringelstein, M. van der Linden, M. Y. Cil, A. Al-Lahham, and F. J. Schmitz. 2005. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. J. Clin. Microbiol. 43:1294-1300.[Abstract/Free Full Text]
  28. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.[Free Full Text]
  29. Schmitz, F. J., M. Perdikouli, A. Beeck, J. Verhoef, and A. C. Fluit. 2001. Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates. Int. J. Antimicrob. Agents 18:433-436.[CrossRef][Medline]
  30. Seral, C., F. J. Castillo, M. C. Rubio-Calvo, A. Fenoll, C. García, and R. Gómez-Lus. 2001. Distribution of resistance genes tet(M), aph3'-II, catpC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harboring erm(B) and mef(A) genes in Spain. J. Antimicrob. Chemother. 47:863-866.[Abstract/Free Full Text]
  31. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by efflux system. Antimicrob. Agents Chemother. 40:1817-1824.[Abstract]
  32. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.[Abstract]
  33. Tenover, F. C., R. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]
  34. Wierzbowski, A. K., D. Swedlo, D. Boyd, M. Mulvey, K. A. Nichol, D. J. Hoban, and G. G. Zhanel. 2005. Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002. Antimicrob. Agents Chemother. 49:1257-1261.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, September 2006, p. 3162-3165, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00269-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ardanuy, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ardanuy, C.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS